Literature DB >> 11376556

Low expression myeloperoxidase genotype negatively associated with Helicobacter pylori infection.

N Hamajima1, K Matsuo, T Suzuki, T Nakamura, A Matsuura, K Tajima, S Tominaga.   

Abstract

Our previous study revealed that a polymorphism of the interleukin (IL) 1B gene, encoding the pro-inflammatory cytokine IL-1 beta, influenced the prevalence of persistent Helicobacter pylori (HP) infection. In this paper, a polymorphism of another inflammation-related enzyme, myeloperoxidase (MPO), was examined with respect to association with the HP infection. The polymorphism is due to a G-to-A transition at - 463 in the promoter region of MPO. The G allele is the wild type with normal expression, while the A allele is a low expression allele. The subjects were 241 non-cancer outpatients (118 males and 123 females) aged 39 to 69 who participated in an HP eradication program at Aichi Cancer Center Hospital. High-molecular weight Campylobacter-Associated-Protein (HM-CAP) ELISA (Enteric Products Ins., Westbury, NY) was used for the identification of HP-infected participants. The frequency was 79.7% (192 / 241) for the GG genotype, 19.5% (47 / 241) for the GA genotype, and 0.8% (2 / 241) for the AA genotype. The sex-age-adjusted odds ratio (OR) relative to GG was 0.69 (95% confidence interval (CI), 0.35 -- 1.35) for individuals with the A allele, but among male participants the OR was 0.31 (0.11 -- 0.84). Subgroup analysis revealed significantly reduced ORs with the GA / AA genotypes for current smokers (0.19, 0.04 -- 0.96), and for those who were occasional / no milk drinkers (0.25, 0.09 -- 0.72). These findings are consistent with the results for IL-1B in our earlier study, suggesting that inflammatory responses in the gastric mucosa may influence persistent HP infection, and that smoking and milk intake may be effect-modifiers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376556      PMCID: PMC5926737          DOI: 10.1111/j.1349-7006.2001.tb01120.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  35 in total

1.  Myeloperoxidase genetic polymorphism and lung cancer risk.

Authors:  S J London; T A Lehman; J A Taylor
Journal:  Cancer Res       Date:  1997-11-15       Impact factor: 12.701

2.  Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant--463A of the myeloperoxidase gene.

Authors:  I Cascorbi; S Henning; J Brockmöller; J Gephart; C Meisel; J M Müller; R Loddenkemper; I Roots
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

3.  Chronic atrophic gastritis and Helicobacter pylori infection among Japanese Americans in Seattle.

Authors:  T Namekata; K Miki; M Kimmey; T Fritsche; D Hughes; D Moore; K Suzuki
Journal:  Am J Epidemiol       Date:  2000-04-15       Impact factor: 4.897

Review 4.  How is Helicobacter pylori transmitted?

Authors:  D R Cave
Journal:  Gastroenterology       Date:  1997-12       Impact factor: 22.682

5.  Helicobacter pylori water-soluble surface proteins activate human neutrophils and up-regulate expression of CXC chemokines.

Authors:  J S Kim; H C Jung; J M Kim; I S Song; C Y Kim
Journal:  Dig Dis Sci       Date:  2000-01       Impact factor: 3.199

6.  An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element.

Authors:  F J Piedrafita; R B Molander; G Vansant; E A Orlova; M Pfahl; W F Reynolds
Journal:  J Biol Chem       Date:  1996-06-14       Impact factor: 5.157

7.  Evidence for the essential role of Helicobacter pylori in gastric ulcer disease.

Authors:  J Labenz; G Börsch
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

8.  A sensitive and specific serologic test for detection of Campylobacter pylori infection.

Authors:  D J Evans; D G Evans; D Y Graham; P D Klein
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

9.  Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group.

Authors: 
Journal:  Gut       Date:  1993-12       Impact factor: 23.059

10.  Lifestyle and anti-Helicobacter pylori immunoglobulin G antibody among outpatients.

Authors:  N Hamajima; M Inoue; K Tajima; S Tominaga; A Matsuura; S Kobayashi; Y Ariyoshi
Journal:  Jpn J Cancer Res       Date:  1997-11
View more
  6 in total

Review 1.  Pathogenesis of Helicobacter pylori infection.

Authors:  Johannes G Kusters; Arnoud H M van Vliet; Ernst J Kuipers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

2.  Susceptibility to Helicobacter pylori infection: results of an epidemiological investigation among gastric cancer patients.

Authors:  Nikola Panic; Elena Mastrostefano; Emanuele Leoncini; Roberto Persiani; Dario Arzani; Rosarita Amore; Riccardo Ricci; Federico Sicoli; Stefano Sioletic; Milutin Bulajic; Domenico D' Ugo; Walter Ricciardi; Stefania Boccia
Journal:  Mol Biol Rep       Date:  2014-02-14       Impact factor: 2.316

3.  Effects of the myeloperoxidase 463 gene polymorphisms on development of atrophy in H pylori infected or noninfected gastroduodenal disease.

Authors:  Omer Yilmaz; Hakan Dursun; Nesrin Gürsan; Ibrahim Pirim; Arif Yilmaz; Nihat Okcu
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

4.  Aggressive periodontitis: An appraisal of systemic effects on its etiology-genetic aspect.

Authors:  Kundu Debabrata; Bandyopadhyay Prasanta; Nair Vineet; Garg Anshul; Saha Arindam; Das Satadal
Journal:  J Indian Soc Periodontol       Date:  2015 Mar-Apr

5.  No association between angiotensin I converting enzyme (ACE) I/D polymorphism and gastric cancer risk among Japanese.

Authors:  Satoshi Hibi; Yasuyuki Goto; Takafumi Ando; Keitaro Matsuo; Kenji Wakai; Kazuo Tajima; Hidemi Goto; Nobuyuki Hamajima
Journal:  Nagoya J Med Sci       Date:  2011-08       Impact factor: 1.131

6.  Helicobacter pylori seropositivity among 963 Japanese Brazilians according to sex, age, generation, and lifestyle factors.

Authors:  L S Ito; S M Oba; N Hamajima; S K Marie; M Uno; S K Shinjo; A Kino; F Lavilla; M Inoue; K Tajima; S Tominaga
Journal:  Jpn J Cancer Res       Date:  2001-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.